Offers
acetone-serum

AML Cytogenetics 1

AML Cytogenetics 1 is an advanced diagnostic testing panel employed to analyze patients who are suspected to have Acute Myeloid Leukemia (AML), a type of cancer that affects the bone marrow and blood. AML Cytogenetics 1 combines karyotyping with Fluorescence In Situ Hybridization (FISH) tests. Karyotyping helps in examining the number and structure of chromosomes in blood or bone marrow cells. The FISH tests are targeted to identify specific chromosomal abnormalities associated with AML, specifically AML-ETO, Inv(16), MLL, and PML/RARA. These genetic alterations are significant in the diagnosis and categorization of AML and have implications for treatment decisions and prognosis.


  • Test NameAML Cytogenetics 1 (Karyotyping + FISH for AML-ETO + Inv(16) + MLL + PML/RARA)
  • Sample TypeBone Marrow or Blood
  • Preparations RequiredNo special preparation such as fasting is required for this test. However, it’s vital to inform your doctor about any medications being taken.
  • Report Time12 Days for Karyotype & 5 Days for FISH

What is Acute Myeloid Leukemia (AML)?

AML is a form of cancer that begins in the bone marrow and results in rapid production of abnormal myeloblasts, a type of white blood cell. These abnormal cells interfere with the production of normal blood cells.

Why is the AML Cytogenetics 1 panel important?

This panel is essential for the proper diagnosis and categorization of AML. By detecting specific chromosomal abnormalities, the panel can help identify the subtype of AML, which is crucial for determining prognosis and guiding treatment decisions.

Home Sample Collection Process
1
Book your convenient slot
Book your convenient slot
2
Sample Collection by Phlebotomist
Sample Collection by Phlebotomist
3
Reporting of the sample at lab
Reporting of the sample at lab
4
Download Reports
Download Reports
Frequently Asked Questions

The panel offers detailed information regarding the chromosomal structure and specific abnormalities such as AML-ETO, Inv(16), MLL, and PML/RARA. This information is crucial for diagnosing AML, identifying its subtype, and understanding its behavior.

This test is usually recommended when there are signs or symptoms indicative of leukemia, such as fatigue, fever, or abnormal blood counts. It’s also used for monitoring the disease during treatment.

Normal results would show no chromosomal abnormalities. However, in AML, specific chromosomal abnormalities can be present, and identifying these is essential for diagnosis and treatment.

Genetic mutations, the presence of leukemia cells, and certain medications can affect the test results. It’s important to discuss all medications and supplements you are taking with your doctor.

The risks are comparable to those of a regular blood draw. If a bone marrow sample is needed, there may be additional risks, such as infection or bleeding at the sample site.

The identification of specific chromosomal abnormalities allows doctors to tailor treatment strategies based on the subtype of AML, which can be more effective in managing the disease.

If the test results are abnormal, it is critical to consult a hematologist or an oncologist who specializes in blood cancers.

This test is usually performed at the time of diagnosis. It may be repeated during treatment to monitor the response to therapy or to check for recurrence.

FISH allows for the detection of specific genetic changes and chromosomal rearrangements that are too small to be seen with karyotyping. It helps in identifying specific subtypes of AML, which can be critical for prognosis and treatment.

Karyotyping is a test that evaluates the number and structure of chromosomes in cells. In AML, karyotyping is used to find out if there are chromosomal changes that might be causing or advancing the leukemia.

While lifestyle and dietary changes may contribute to the overall health of a patient with AML, they are unlikely to significantly impact the results of the genetic tests or the course of the disease.

Understanding the genetic makeup of Acute Myeloid Leukemia is crucial for ensuring the best possible outcome. The AML Cytogenetics 1 panel is an essential component of the diagnostic process and guides the decision-making for treatment strategies. It is vital to keep in communication with your doctor and actively participate in the management and treatment plan.

AML cytogenetics 1 (Karyotyping + FISH for AML-ETO + Inv(16)+ MLL + PML /RARA)
₹ 15900
Book Your Slot
Locations Near You in Hyderabad
  • 4KM from Madhapur
  • 3KM from Banjara Hills
  • 1.9KM from Yusufguda
  • 3KM from Madhura Nagar
  • 5KM from Shaikpet